To recover your password please fill in your email address
Please fill in below form to create an account with us
A nurse-led model of care is making a difference.
ENZAMET scoops all three ACTA awards
CLARITY 2.0 study looks at the Dimerix lead candidate DMX-200 combined with Angiotensin Receptor Blockers to treat respiratory issues associated with COVID19.
Here's how we are helping the response to the pandemic.
Hear from one of our LIPID trial participants.
01/12/20
12/11/20
22/10/20
14/10/20
18/09/20
13/08/20
12/08/20
